Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Clinical studies begin with BNP-7787

Sep. 12, 1997

Final phase I/IIa data reported on oral Panretin in APL

Sep. 11, 1997

Letrozole approved in Canada

Sep. 10, 1997

Heat treatment for liver cancer assessed in clinical trials

Sep. 10, 1997

Another Isis oligonucleotide enters clinical testing

Sep. 10, 1997

Bexxar now administered on outpatient basis

Sep. 10, 1997

GSH prevents cisplatin-induced toxicity

Sep. 9, 1997

Treatment for preleukemic disorder from Milkhaus enters phase III

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...